Monterey Bio Acquisition Corporation
Monterey Bio Acquisition Corporation (MTRY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MTRY · as of Jun 9, 2026
Key Statistics
Explore Monterey Bio Acquisition Corporation Data
mtry stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mtry competitorsMTRY
ACAB
GRDI
GTI
HOLO
PRSRStock Performance
Full HistoryAbout Monterey Bio Acquisition Corporation
Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock excha…
what is monterey bio acquisition corporation · mtry stock overview · monterey bio acquisition corporation company profile · who is monterey bio acquisition corporation ceo · mtry NASDAQ · monterey bio acquisition corporation headquarters · monterey bio acquisition corporation business segments
About Stock Overview & Key Data
Monterey Bio Acquisition Corporation (MTRY) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Nov 22, 2021. As of the latest trading session, MTRY stock price is $11.14, with a market capitalization of $48.3M. The stock has returned +8.05% over the past 12 months and +6.60% year-to-date.
In fiscal year 2022, Monterey Bio Acquisition Corporation reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Monterey Bio Acquisition Corporation (MTRY) stock price is $11.14. The stock is traded on NASDAQ under the ticker symbol MTRY. The 52-week range is $10.21 – $12.00.